Share “News Summary: Amgen 4Q profit drops, costs...”

News Summary: Amgen 4Q profit drops, costs rise

Published on NewsOK Modified: January 23, 2013 at 7:51 pm •  Published: January 23, 2013
Advertisement

PROFIT SLUMP: Biotech giant Amgen Inc.'s fourth-quarter net income dropped 16 percent to $788 million, or $1.01 per share, due to higher spending on production, marketing, research and other items.

SALES SURGE: Revenue rose 11 percent to $4.42 billion, as sales of immune disorder treatment Enbrel and four other drugs climbed by double digits. But part of the revenue jump was due to price increases.

2013 FORECASTS: Amgen's forecast is for earnings per share of $6.85 to $7.15. It expects revenue of $17.8 billion to $18.2 billion — about the level it previously forecast for 2015.


AROUND THE WEB

  1. 1
    How to tell if your apps are snooping on you
  2. 2
    Tulsa mother's invention featured in new issue of Parents magazine
  3. 3
    Texas secessionists launch petition drive for vote to break away
  4. 4
    'Boy lover' professor still employed at U-M despite federal indictment
  5. 5
    Redskins name Kirk Cousins starting quarterback for entire season. What's next for RGIII?
+ show more

FEATURED JOBS



× Trending business Article